×
Back to Agenda
Session 10 (Parallel Session) : CMC and Non-Clinical
Session Chair(s)
Dong Hee Na, PHD
Professor, Chung-Ang University, Korea, Republic of
In-sook Park, PHD
Former Director General, Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Thomas Steger-Hartmann, PHD
Senior Project Lead Innovative Health Initiative, VP, Bayer Pharma AG, Germany
Sukmo Kang, DVM, PHD
Director, Business Development / Research Planning, BIOTOXTECH, BTT Group, Korea, Republic of
Jaewoon Son, PHD
MSAT/DP Team Leader, GC BioPharma, Korea, Republic of
Ohseok Kwon, PHD
Recombinant Protein Products Division, Ministry of Food and Drug Safety, Korea, Republic of
Young Joo Park, PHD, MPH
VP, Korea, Singapore, and Southeast Asia, DIA, Korea, Republic of
Have an account?